Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
07/2012
07/05/2012US20120172435 Methods for treating acute acoustic trauma
07/05/2012US20120172427 (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide tablet formulations with improved stability
07/05/2012US20120172421 2, 6 xylidine derivatives for the treatment of pain
07/05/2012US20120172419 Reagents and methods for modulating cone photoreceptor activity
07/05/2012US20120172396 2-adamantylurea derivatives as selective 11b-hsd1 inhibitors
07/05/2012US20120172393 (4-Phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone Compounds and Their Use
07/05/2012US20120172382 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
07/05/2012US20120172376 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
07/05/2012US20120172359 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
07/05/2012US20120172352 Pyrazoline dione derivatives as nadph oxidase inhibitors
07/05/2012US20120172339 Angiogenic resorcinol derivatives
07/05/2012US20120172300 Remodeling and glycopegylation of fibroblast growth factor (fgf)
07/05/2012US20120171284 Celecoxib compositions
07/05/2012US20120171280 Method of making liposomes, liposome compositions made by the methods, and methods of using the same
07/05/2012US20120171253 Fibromodulin Peptide
07/05/2012US20120171233 Peptide inhibitors for mediating stress responses
07/05/2012US20120171216 Palmitated monoclonal antibody
07/05/2012US20120171204 Compositions and methods for the treatment and diagnosis of immune disorders
07/05/2012US20120171203 Activin receptor-like kinase-1 compositions and methods of use
07/05/2012US20120171202 Rage Fusion Proteins And Methods Of Use
07/05/2012US20120171195 Anti-hla-e antibodies, therapeutic immunomodulatory antibodies to human hla-e heavy chain, useful as ivig mimetics and methods of their use
07/05/2012US20120171126 NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOF
07/05/2012US20120171118 Treatment of meningeal and neural diseases
07/05/2012CA2823148A1 Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
07/04/2012EP2471818A1 Humanized anti-factor D antibodies and uses thereof
07/04/2012EP2471777A1 Novel tetrahydroisoquinoline compounds
07/04/2012EP2470519A1 Treatment of macular degeneration
07/04/2012EP2470191A1 Methods and compositions for preventing or treating ophthalmic conditions
07/04/2012EP2470015A1 Methods for treating acute acoustic trauma
07/04/2012EP1817036B1 Modulators of muscarinic receptors
07/04/2012EP1556410B1 Peptide fragments of the harp factor inhibiting angiogenesis
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012EP1349580B2 Process to improve stability of a pharmaceutical composition
07/04/2012CN1962641B Metalloproteinase inhibitors
07/04/2012CN1449386B Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
07/04/2012CN102548985A Substituted carbonyl compounds
07/04/2012CN102548582A Eye drops
07/04/2012CN102548575A Eye drops
07/04/2012CN102548562A Ophthalmic composition
07/04/2012CN102548561A Ethyleneoxide butyleneoxide block copolymer compositions
07/04/2012CN102548548A Pharmaceutical composition for use in medical and veterinary ophthalmology
07/04/2012CN102532264A Peptide-based compounds
07/04/2012CN102532144A Novel indoleamine-2,3-dioxygenase inhibitor as well as preparation method and application thereof
07/04/2012CN102532135A Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
07/04/2012CN102532042A Aryl urea compound as well as intermediate and application thereof
07/04/2012CN102531948A 氨基-甲基取代的四环素类化合物 Amino - methyl-substituted tetracycline compounds
07/04/2012CN102526759A Dendritic-polymer-based high-bioavailability oral puerarin preparation
07/04/2012CN102526738A Compound ophthalmic preparation and preparation method as well as application thereof
07/04/2012CN102526734A Medicine composition for treating age-related hearing loss (ARHL) and application thereof
07/04/2012CN102526719A Application of influenza vaccine in preparation of medicament for treating allergic diseases and allergy related diseases
07/04/2012CN102526462A Traditional Chinese medicine composition for treating tinnitus
07/04/2012CN102526429A Chinese medicinal preparation for treating nearsightedness and asthenopia and preparation method thereof
07/04/2012CN102526341A Chinese medicine for treating and relaying age-related cataract advancement
07/04/2012CN102526298A Traditional Chinese medicinal composition for treating purulent otitis media
07/04/2012CN102526282A External-use health care product for lowering intraocular pressure of diabetes mellitus eye disease patient
07/04/2012CN102526277A Method for extracting total alkaloid in stem bark and leaves of nauclea offcinalis
07/04/2012CN102526171A Eye health care product capable of preventing and delaying senile macular degeneration and manufacture method
07/04/2012CN102526132A Antifungal ear drops and preparation method thereof
07/04/2012CN102526112A Sustained-release pearl clear-sighted eye drops and preparation method thereof
07/04/2012CN102526079A 治疗脱髓鞘疾病的鞘氨醇-1-磷酸受体激动剂 Treatment of demyelinating diseases of the sphingosine-1-phosphate receptor agonist,
07/04/2012CN102526064A Product containing prostaglandin having fluorine atom in its molecule
07/04/2012CN102526056A Voriconazole ear drop and preparation method and application thereof
07/04/2012CN102526051A Eye ointment for treating fungal keratitis
07/04/2012CN102525980A Children cetirizine hydrochloride composition
07/04/2012CN102525917A Nimodipine micelle injection and preparation method thereof
07/04/2012CN102525906A Bendazol eye drops
07/04/2012CN102525889A Ornidazole ophthalmic gel and preparation method and application thereof
07/04/2012CN102525887A Cyclosporine-containing ophthalmic emulsion gel and preparation method thereof
07/04/2012CN102210841B Chinese medicinal preparation for treating central serous retinopathy
07/04/2012CN102121023B Mutant human plasminogen kringle5, preparation method and application thereof
07/04/2012CN101987109B Ophthalmic composition containing povidone iodine and cyclodextrin included glucocorticoid
07/04/2012CN101869674B Chinese medicinal composition for treating vertigo
07/04/2012CN101766695B Point eye mask and preparation method and application thereof
07/04/2012CN101766628B Ophthalmic bacterial-infection resisting medicine for external use
07/04/2012CN101757621B Cyclodextrin inclusion drug composition for ocular inflammation resistance
07/04/2012CN101703503B Application of organic dicarboxylic acid salts in preparing medicaments for preventing and treating cataract
07/04/2012CN101528229B Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof
07/04/2012CN101468050B External use medicament for treating viral keratitis and preparation method thereof
07/04/2012CN101390997B Jianmu capsule and preparation method thereof
07/04/2012CN101095763B Decoction medicine for treating acute catarrhal conjunctivitis and method for preparing the same
07/03/2012US8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
07/03/2012US8211671 Activatable recombinant neurotoxins
07/03/2012CA2661960C Noninvasive measurements of chemical substances
07/03/2012CA2571782C Prostaglandin analogs
07/03/2012CA2521648C Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
07/03/2012CA2485850C 8-azaprostaglandin analogs as agents for lowering intraocular pressure
07/03/2012CA2388818C C-aryl glucoside sglt2 inhibitors and method
06/2012
06/28/2012WO2012088044A2 Compositions and methods for improving ocular surface health, corneal clarity, optical function and maintaining visual acuity
06/28/2012WO2012086727A1 Novel substituted isoquinoline derivative
06/28/2012WO2012086184A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
06/28/2012WO2012085318A1 Lipid nanoparticles for treating ocular diseases
06/28/2012WO2012085165A1 Tear substitutes
06/28/2012WO2012085139A1 Otic composition for companion animals
06/28/2012WO2012085068A1 Kit-in-parts for cleaning and treating ears of companion animals
06/28/2012WO2012067427A9 Pharmaceutical composition containing lk8 protein as an active ingredient for preventing or treating diabetic retinopathy or age-related macular degeneration
06/28/2012US20120165383 Inflammatory eye disease
06/28/2012US20120165382 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
06/28/2012US20120165372 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
06/28/2012US20120165354 Treatment method
06/28/2012US20120165337 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 531